
Keywords: Pharmaceutical Materials Science (PMS); Drug research and development; Hydrophobic and amphiphilic drugs; Drug self-aggregation; Structure–biological performance relationship; NanotechnologyBBB, blood brain barrier; CAC, critical aggregation concentration